Pricing Log in Create free account

Lipella Pharmaceuticals Inc. (LIPO) vs Onconetix, Inc. (ONCO)

Lipella Pharmaceuticals Inc. and Onconetix, Inc. are both Biotechnology companies. Lipella Pharmaceuticals Inc. and Onconetix, Inc. are of similar size ($3.4M and $3.2M). Lipella Pharmaceuticals Inc. grew revenue faster over the last twelve months: −7.29% against −51.3%. Lipella Pharmaceuticals Inc. has the higher net margin (0.00% vs −1,578.6%) and the higher return on invested capital (0.00% vs −135.4%). Across the 14 metrics below, Lipella Pharmaceuticals Inc. leads on 10 and Onconetix, Inc. on 4.

Valuation

Metric LIPO ONCO Biotechnology median
P/E n/m n/m 10.60
P/S n/m 23.65 9.40
P/B n/m 1.13 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.29 n/m 0.66
EV/Sales (3.31) 14.63 9.02
Earnings yield 0.00% (2,931.13%) (32.88%)
Free cash flow yield 0.00% (67.68%) (23.13%)

Profitability

Metric LIPO ONCO Biotechnology median
Gross margin 100.00% 80.38% 68.51%
Operating margin 0.00% (2,524.73%) 0.00%
Net margin 0.00% (1,578.60%) 0.00%
Free cash flow margin 0.00% (1,595.90%) 0.00%
Return on equity (361.77%) (105.23%) (51.96%)
Return on assets (236.36%) (57.37%) (46.06%)
Return on invested capital 0.00% (135.42%) 0.00%

Growth

Metric LIPO ONCO Biotechnology median
Revenue growth (TTM) (7.29%) (51.33%) 6.76%
EPS growth (last fiscal year) 22.24% 99.09% 29.88%
Revenue growth, 5-year CAGR (5.04%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LIPO ONCO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.24 2.21 4.97
Net debt to EBITDA 0.43 0.29 1.01

Dividend

Metric LIPO ONCO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LIPO ONCO Biotechnology median
Market cap 3.39m 3.24m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack